Genprex Inc (GNPX)

Aug 14, 2026

Genprex, Inc. Q2 2026: Net loss $(4.45M), EPS $(9.40) — 10-Q Summary - TradingView

Aug 14, 2026

Aug 14, 2026

Genprex (NASDAQ: GNPX) details Q2 loss and cash runway into 2027 - Stock Titan

Aug 14, 2026

Aug 14, 2026

GNPX|Genprex Inc|Price:4.320|Chg%:-0.550 - TradingKey

Aug 14, 2026

Aug 11, 2026

Genprex Inc (STU:2DE1) Stock Earnings Transcripts - GuruFocus

Aug 11, 2026

Aug 11, 2026

Genprex Inc (STU:2DE1) Stock Price & 30 Year Financial Data - GuruFocus

Aug 11, 2026

Aug 09, 2026

Genprex Inc (GNPX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026

Aug 07, 2026

Genprex Inc (GNPX) Stock News Today - TradingKey

Aug 07, 2026

Aug 06, 2026

Genprex Regains Nasdaq Compliance, Listing Status Secured - The Globe and Mail

Aug 06, 2026

Aug 05, 2026

Genprex, Inc. (NASDAQ: GNPX) regains Nasdaq minimum bid compliance - Stock Titan

Aug 05, 2026

Aug 04, 2026

Genprex partners with Roche Diagnostics on biomarker validation for NSCLC - Yahoo Finance

Aug 04, 2026

Aug 03, 2026

Genprex, Roche Partner on NSCLC Biomarker Validation - TipRanks

Aug 03, 2026

Aug 03, 2026

Genprex Shares Rise After Collaboration With Roche Diagnostics - finance.yahoo.com

Aug 03, 2026

Aug 03, 2026

GNPX Stock Draws Trader Focus After Wild Price Swing - StocksToTrade

Aug 03, 2026

Aug 03, 2026

Why is Genprex stock sliding today? By Investing.com - Investing.com Canada

Aug 03, 2026

Aug 03, 2026

Weekly Recap: Nasdaq exception and Roche Diagnostics TROP2 validation - TradingView

Aug 03, 2026

Aug 03, 2026

Genprex stock rises on Roche Diagnostics collaboration By Investing.com - Investing.com India

Aug 03, 2026

Aug 03, 2026

Genprex partners with Roche on lung cancer biomarker studies - Investing.com Nigeria

Aug 03, 2026

Aug 03, 2026

Genprex partners with Roche on lung cancer biomarker studies By Investing.com - Investing.com Canada

Aug 03, 2026

Aug 03, 2026

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies - marketscreener.com

Aug 03, 2026

Jul 31, 2026

Genprex Granted Nasdaq Listing Exception Amid Compliance Push - The Globe and Mail

Jul 31, 2026

Jul 30, 2026

Genprex Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Jul 30, 2026

Jul 30, 2026

Nasdaq panel grants Genprex (NASDAQ: GNPX) conditional listing reprieve - Stock Titan

Jul 30, 2026

Jul 28, 2026

Genprex Inc (GNPX) Institutional Confidence - TradingKey

Jul 28, 2026

Jul 27, 2026

Genprex Inc (GNPX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 26, 2026

Genprex Inc (GNPX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 26, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

GNPX|Genprex Inc|Price:7.735|Chg%:-0.075 - TradingKey

Jul 25, 2026

Jul 25, 2026

GNPX|Genprex Inc|Price:4.700|Chg%:+0.230 - TradingKey

Jul 25, 2026

Jul 24, 2026

Genprex Inc Revenue Breakdown – LSE:0A8I - TradingView

Jul 24, 2026

Jul 23, 2026

AMD Stock Price Today, Analysis, News and Trading Ideas - Stocktwits

Jul 23, 2026

Jul 20, 2026

Gross margin % of Genprex Inc – MUN:2DE1 - TradingView

Jul 20, 2026

Jul 20, 2026

CapEx per share of Genprex Inc – MUN:2DE1 - TradingView

Jul 20, 2026

Jul 20, 2026

Dilution adjustment of Genprex Inc – MUN:2DE1 - TradingView

Jul 20, 2026

Jul 20, 2026

Total debt of Genprex Inc – MUN:2DE1 - TradingView

Jul 20, 2026

Jul 20, 2026

Total revenue of Genprex Inc – MUN:2DE1 - TradingView

Jul 20, 2026

Jul 20, 2026

Genprex (GNPX) Virtual Road Show with CEO Rodney Varner Transcript - GuruFocus

Jul 20, 2026

Jul 20, 2026

Genprex Inc C-Suite Interview with Noble Capital Markets Transcript - GuruFocus

Jul 20, 2026

Jul 20, 2026

Genprex (GNPX) Channelchek C-Suite Series, CEO Rodney Varner interview with Noble's Dr. Ahu Demir Transcript - GuruFocus

Jul 20, 2026

Jul 20, 2026

Genprex Inc Global One Media Interview Transcript - GuruFocus

Jul 20, 2026

Jul 20, 2026

Genprex Inc at H C Wainwright Global Investment Conference (Virtual) Transcript - GuruFocus

Jul 20, 2026

Jul 19, 2026

Cash flow from financing activities of Genprex Inc – FWB:2DE1 - TradingView

Jul 19, 2026

Jul 19, 2026

Net income of Genprex Inc – MUN:2DE1 - TradingView

Jul 19, 2026

Jul 19, 2026

Genprex Inc (FRA:2DE1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Jul 19, 2026

Jul 19, 2026

Genprex Inc (FRA:2DE1) Stock Earnings Transcripts - GuruFocus

Jul 19, 2026

Jul 19, 2026

Net income of Genprex Inc – FWB:2DE1 - TradingView

Jul 19, 2026

Jul 17, 2026

Genprex Inc (STU:2DE1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Jul 17, 2026

Jul 17, 2026

Genprex (GNPX) Q1 2026 Earnings: Pre-Revenue Biotech Reports Net Loss of -$0.64 Per ShareEarnings Call Q&A - dars.gov.et

Jul 17, 2026

Jul 16, 2026

Genprex Announces Reverse Stock Split Amid Nasdaq Compliance Push - The Globe and Mail

Jul 16, 2026

Jul 12, 2026

Genprex Inc. (GNPX) Edges Higher Amid Controlled Trading: Key Levels to WatchgetLinesFromResByArray error: size == 0 - dars.gov.et

Jul 12, 2026

Jul 11, 2026

Stock Splits Calendar for: - Yahoo! Finance Canada

Jul 11, 2026

Jul 08, 2026

Genprex Inc. (GNPX) Slides 5% as Biotech Stock Tests Key SupportFibonacci Arc - dars.gov.et

Jul 08, 2026

Jul 06, 2026

Genprex Shows Resilience: GNPX Climbs 7.8% on Renewed Biotech InterestAnchored VWAP - DonanımHaber

Jul 06, 2026